Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy
- PMID: 20142328
- DOI: 10.1242/dmm.003772
Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy
Abstract
Approximately 2.5 million people worldwide are clinically blind because of diabetic retinopathy. In the non-proliferative stage, the pathophysiology of this ocular manifestation of diabetes presents as morphological and functional disruption of the retinal vasculature, and dysfunction of retinal neurons. However, it is uncertain whether the vascular and neuronal changes are interdependent or independent events. In addition, the identity of the retinal neurons that are most susceptible to the hyperglycaemia associated with diabetes is unclear. Here, we characterise a novel model of non-proliferative diabetic retinopathy in adult zebrafish, in which the zebrafish were subjected to oscillating hyperglycaemia for 30 days. Visual function is diminished in hyperglycaemic fish. Significantly, hyperglycaemia disrupts cone photoreceptor neurons the most, as evidenced by prominent morphological degeneration and dysfunctional cone-mediated electroretinograms. Disturbances in the morphological integrity of the blood-retinal barrier were also evident. However, we demonstrate that these early vascular changes are not sufficient to induce cone photoreceptor dysfunction, suggesting that the vascular and neuronal complications in diabetic retinopathy can arise independently. Current treatments for diabetic retinopathy target the vascular complications. Our data suggest that cone photoreceptor dysfunction is a clinical hallmark of diabetic retinopathy and that the debilitating blindness associated with diabetic retinopathy may be halted by neuroprotection of cones.
Similar articles
-
Evidence for photoreceptor changes in patients with diabetic retinopathy.Invest Ophthalmol Vis Sci. 1997 Oct;38(11):2355-65. Invest Ophthalmol Vis Sci. 1997. PMID: 9344359
-
Paired-flash identification of rod and cone dysfunction in the diabetic rat.Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4592-600. doi: 10.1167/iovs.04-0842. Invest Ophthalmol Vis Sci. 2004. PMID: 15557472
-
The sand rat, Psammomys obesus, develops type 2 diabetic retinopathy similar to humans.Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8993-9004. doi: 10.1167/iovs.11-8423. Invest Ophthalmol Vis Sci. 2011. PMID: 21989730
-
How to overcome retinal neuropathy: the fight against angiogenesis-related blindness.Arch Pharm Res. 2010 Oct;33(10):1557-65. doi: 10.1007/s12272-010-1007-6. Epub 2010 Oct 30. Arch Pharm Res. 2010. PMID: 21052933 Review.
-
Molecular mechanisms of vascular permeability in diabetic retinopathy.Semin Ophthalmol. 1999 Dec;14(4):240-8. doi: 10.3109/08820539909069543. Semin Ophthalmol. 1999. PMID: 10758225 Review.
Cited by
-
Noncaloric monosaccharides induce excessive sprouting angiogenesis in zebrafish via foxo1a-marcksl1a signal.Elife. 2024 Oct 4;13:RP95427. doi: 10.7554/eLife.95427. Elife. 2024. PMID: 39365738 Free PMC article.
-
Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics.J Biomed Sci. 2013 Jun 20;20(1):38. doi: 10.1186/1423-0127-20-38. J Biomed Sci. 2013. PMID: 23786217 Free PMC article. Review.
-
Advancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish.Cells. 2021 May 25;10(6):1313. doi: 10.3390/cells10061313. Cells. 2021. PMID: 34070439 Free PMC article. Review.
-
Zebrafish Model in Ophthalmology to Study Disease Mechanism and Drug Discovery.Pharmaceuticals (Basel). 2021 Jul 25;14(8):716. doi: 10.3390/ph14080716. Pharmaceuticals (Basel). 2021. PMID: 34451814 Free PMC article. Review.
-
Differential Responses of Neural Retina Progenitor Populations to Chronic Hyperglycemia.Cells. 2021 Nov 22;10(11):3265. doi: 10.3390/cells10113265. Cells. 2021. PMID: 34831487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases